LRMR | Complete Larimar Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Phreesia has an analyst consensus of Strong Buy, with a price target consensus of $29.20, implying a 39.4% upside from current levels. In a report issued on December 2, Canaccord Genuity also maintained a Buy rating on the stock with a $34.00 price target. ...